Compare LCNB & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | LCNB | LFCR |
|---|---|---|
| Founded | 1877 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 223.1M | 190.9M |
| IPO Year | 1999 | 1996 |
| Metric | LCNB | LFCR |
|---|---|---|
| Price | $19.47 | $4.14 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $6.00 |
| AVG Volume (30 Days) | 23.0K | ★ 128.1K |
| Earning Date | 04-22-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.43% | N/A |
| EPS Growth | ★ 68.04 | N/A |
| EPS | ★ 0.84 | N/A |
| Revenue | $6,445,000.00 | ★ $557,559,000.00 |
| Revenue This Year | $8.50 | N/A |
| Revenue Next Year | $3.66 | $5.04 |
| P/E Ratio | $22.75 | ★ N/A |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $14.31 | $3.63 |
| 52 Week High | $21.32 | $8.98 |
| Indicator | LCNB | LFCR |
|---|---|---|
| Relative Strength Index (RSI) | 49.57 | 42.65 |
| Support Level | $19.01 | $4.24 |
| Resistance Level | $20.48 | $4.88 |
| Average True Range (ATR) | 0.47 | 0.22 |
| MACD | -0.04 | -0.03 |
| Stochastic Oscillator | 51.62 | 30.12 |
LCNB Corp operates within the financial sector in the United States. As the holding company of the National Bank, it conducts the business of providing commercial and personal banking services. Its suite of banking products includes commercial and industrial loans, consumer loans, safe deposit boxes, night depositories, cashier's checks, utility bill collections, and notary public service. Besides, it provides the avenue of United States Treasury notes, the United States agency notes, certificates of deposit, and equity securities.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that provides services in the development, fill, and finish of complex sterile injectable pharmaceutical products in syringes, vials, and cartridges. The group recognizes revenue in two different product categories, CDMO and HA manufacturing.